-
1Academic Journal
المؤلفون: Thibaudin, Marion, Roussot, Nicolas, Burlot, Chloé, Schmitt, Antonin, Vincent, Julie, Tharin, Zoé, Bengrine, Leila, Bellio, Hélène, Bertaut, Aurélie, Hampe, Léa, Daumoine, Susy, Rederstorff, Emilie, Peroz, Morgane, Huppe, Titouan, Derangère, Valentin, Rageot, David, Simard, John, Truntzer, Caroline, Fumet, Jean David, Ghiringhelli, Francois
المصدر: Signal Transduction & Targeted Therapy; 1/17/2025, Vol. 10 Issue 1, p1-13, 13p
-
2Academic Journal
المؤلفون: Fourrier, Théo, Truntzer, Caroline, Peroz, Morgane, Derangère, Valentin, Vincent, Julie, Bengrine-Lefèvre, Leila, Hennequin, Audrey, Palmier, Rémi, Orry, David, Rabel, Thomas, Ghiringhelli, François
المصدر: Cancers; Jan2025, Vol. 17 Issue 1, p88, 21p
-
3Academic Journal
المؤلفون: Thibaudin, Marion, Fumet, Jean-David, Chibaudel, Benoist, Bennouna, Jaafar, Borg, Christophe, Martin-Babau, Jerome, Cohen, Romain, Fonck, Marianne, Taieb, Julien, Limagne, Emeric, Blanc, Julie, Ballot, Elise, Hampe, Léa, Bon, Marjorie, Daumoine, Susy, Peroz, Morgane, Mananet, Hugo, Derangère, Valentin, Boidot, Romain, Michaud, Henri-Alexandre, Laheurte, Caroline, Adotevi, Olivier, Bertaut, Aurélie, Truntzer, Caroline, Ghiringhelli, François
المساهمون: Ligue contre le Cancer, INCa, ARC, LabEx LipSTIC, Région BFC, Isite BFC Program, AstraZeneca, CLCC Georges François Leclerc, AstraZeneca, CLCC Georges François Leclerc
المصدر: Nature Medicine ; volume 29, issue 8, page 2087-2098 ; ISSN 1078-8956 1546-170X
-
4Academic Journal
المؤلفون: Peroz, Morgane1,2,3 (AUTHOR) mperoz@cgfl.fr, Mananet, Hugo1,2,3 (AUTHOR) hmananet@cgfl.fr, Roussot, Nicolas4 (AUTHOR) nroussot@cgfl.fr, Kaderbhai, Courèche Guillaume4 (AUTHOR) cgkaderbhai@cgfl.fr, Derangère, Valentin1,2,3 (AUTHOR) vderangere@cgfl.fr, Truntzer, Caroline1,2,3 (AUTHOR) ctruntzer@cgfl.fr, Ghiringhelli, François1,2,3,4 (AUTHOR) ctruntzer@cgfl.fr
المصدر: Cancers. Sep2024, Vol. 16 Issue 17, p3115. 12p.
مصطلحات موضوعية: *GENOMICS, *TUMOR markers, *METASTASIS, *IMMUNE checkpoint inhibitors, *CANCER chemotherapy, *LUNG tumors, *LUNG cancer, *GENETIC mutation, *PROGRESSION-free survival, *SEQUENCE analysis, *GENOMES, *OVERALL survival